According to Teligent's latest financial reports the company's current revenue (TTM) is $46.29 M. In 2020 the company made a revenue of $45.3 M a decrease over the years 2019 revenue that were of $65.89 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2021 (TTM) | $46.29 M | 2.18% |
2020 | $45.3 M | -31.24% |
2019 | $65.89 M | -0.71% |
2018 | $66.36 M | -1.31% |
2017 | $67.25 M | 0.55% |
2016 | $66.88 M | 51.14% |
2015 | $44.25 M | 31.15% |
2014 | $33.73 M | 85.15% |
2013 | $18.22 M | 112.81% |
2012 | $8.56 M | 9.7% |
2011 | $7.8 M | 28.07% |
2010 | $6.09 M | 61.33% |
2009 | $3.77 M | -7.15% |
2008 | $4.06 M | -11.18% |
2007 | $4.58 M | 74.85% |
2006 | $2.62 M | -8.62% |
2005 | $2.86 M | -8.84% |
2004 | $3.14 M | -11.58% |
2003 | $3.55 M | -51.95% |
2002 | $7.4 M | -54.52% |
2001 | $16.27 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $0.86 B | 1,765.12% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $0.22 M | -99.51% | ๐บ๐ธ USA |